Financing, Equity Capital Markets
XBiotech, Inc.
05/19
|
$40.0 Million
Âé¶¹´«Ã½ served as sole bookrunner for XBiotech Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma